IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 21 - 40 of 1231 stories.
February 6, 2015
The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel) reports a 1.7% rise in sales in the fourth quarter of 2014 compared with...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Tevas-API-business-reports-a-small-increase-in-sales_67603.html
February 6, 2015
Cambrex (East Rutherford, NJ) says its net profits for the fourth quarter of 2014 more than tripled compared with the fourth quarter of 2013, to $27.8 million. Net sales for the fourth...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-huge-rise-in-profits_67609.html
February 5, 2015
Contract manufacturing organizations (CMOs), including many fine chemical makers, are among the big beneficiaries from changes at big pharmaceutical companies, say attendees at...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Informex-2015-CMOs-benefit-from-changes-at-big-pharma_67545.html
February 5, 2015
Pfizer and Hospira (Lake Forest, IL) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world’s leading...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pfizer-to-acquire-Hospira-for-$17-billion_67537.html
February 4, 2015
Regulatory issues, most prominently reform of the Toxic Substances Control Act (TSCA) and trade barriers, have been key topics of discussion at Informex 2015, held this week in New...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Informex-2015-Regulatory-hurdles-persist-as-industry-expects-growth_67510.html
February 3, 2015
Galmed and Perrigo sign API manufacturing deal Galmed Pharmaceuticals (Tel Aviv), a company focused on developing and commercializing a once-daily, oral medication to treat liver...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-3-February-2015_67443.html
February 2, 2015
Amyris (Emeryville, CA) says it plans to offer its synthetic biology discovery and production platform to pharmaceutical makers. Amyris says it will offer an integrated discovery and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Amyris-to-launch-biopharma-platform_67410.html
February 1, 2015
The FTC on Friday cleared Sun Pharmaceutical’s $4 billion proposed acquisition of Ranbaxy Laboratories on condition that the companies divest Ranbaxy’s interests in generic...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FTC-clears-Sun-Pharmas-acquisition-of-Ranbaxy-on-condition-that-they-divest-a-business_67385.html
January 29, 2015
Ash Stevens (Riverview, MI), a provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, says that FDA...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ash-Stevens-to-manufacture-amotosalen-API-for-Cerus_67310.html
January 29, 2015
Galmed Pharmaceuticals (Tel Aviv), a company focused on developing and commercializing a once-daily, oral medication to treat liver diseases and cholesterol gallstones, says that it...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Galmed-and-Perrigo-sign-API-manufacturing-deal_67309.html
January 29, 2015
The European Commission said on Wednesday that it has cleared both GlaxoSmithKline's (GSK) proposed acquisition of Novartis's vaccines business and the proposed creation of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/EU-conditionally-approves-GSK-Novartis-deals_67307.html
January 29, 2015
Umicore (Brussels) says that its precious metals chemistry business unit has appointed a subsidiary of Midas Pharma (Ingelheim, Germany) at Parsippany, NJ, as the exclusive sales agent...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Umicores-API-business-appoints-sales-partner-for-North-America_67298.html
January 27, 2015
Feature Fine chemicals: Stringent regulations prompt return of manufacturing to the West Pharmaceutical ingredient manufacturers are witnessing a rise in demand, and they remain...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-27-January-2015_67232.html
January 26, 2015
MGC Pharma (Tokyo), a wholly owned subsidiary of Mitsubishi Gas Chemical (MGC); and Catalent Pharma Solutions (Somerset, NJ), a leading contract manufacturer of pharmaceuticals, have...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mitsubishi-Gas-Chemical-subsidiary-and-Catalent-sign-deal-for-biosimilars_67193.html
January 23, 2015
FDA, on 22 January, issued an import alert for an active pharmaceutical ingredient (API) manufacturing facility of Ipca Laboratories (Mumbai), located at Ratlam, India. An import alert...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-issues-import-alert-against-Ipca-API-plant_67168.html
January 20, 2015
AMRI receives NIH contract for drug development and manufacturing services Albany Molecular Research Inc. (AMRI; Albany) says that it has received a 10-year federal contract award from...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-20-January-2015_66991.html
January 19, 2015
Albany Molecular Research Inc. (AMRI; Albany) says that it has received a 10-year federal contract award from the National Institutes of Health (NIH; Bethesda, MD) for drug development...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/AMRI-receives-NIH-contract-for-drug-development-and-manufacturing-services_66967.html
January 14, 2015
Shire (Dublin) and NPS Pharmaceuticals (Bedminster, NJ) today announced that they have entered into an agreement for Shire to acquire all the outstanding shares of NPS Pharma for...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Shire-to-acquire-NPS-Pharma-for-$5-2-billion-building-leading-biotech-position_66731.html
January 13, 2015
Active pharmaceutical ingredients (APIs) producer Hovione (Loures, Portugal) says that it has appointed Filipe Gaspar as v.p./R&D. Gaspar will lead the teams based at Lisbon and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Hovione-appoints-head-of-R-and-D_66772.html
January 13, 2015
AMRI to acquire Aptuit’s drug product development and aseptic clinical manufacturing businesses Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has acquired...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-13-January-2015_66781.html
Pages: « Previous  1 [2] 3 4 5 6 7 8 9 10 11 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa